WAVE Life Sciences Ltd (NAS:WVE)
$ 13.41 0.29 (2.21%) Market Cap: 2.05 Bil Enterprise Value: 1.76 Bil PE Ratio: 0 PB Ratio: 14.06 GF Score: 45/100

WAVE Life Sciences Ltd at Stifel CNS Days (Virtual) Transcript

Mar 28, 2022 / 01:15PM GMT
Release Date Price: $2.12 (-2.30%)
Alex Thompson
Stifel, Nicolaus & Company, Incorporated - Analyst

Hey, good morning, everyone. I'm Alex Thompson. I'm the associate here. And Paul Matteis, [here] at Stifel. It's my pleasure to introduce Paul Bolno, CEO of Wave Life Therapeutics this morning. And maybe let's start off with Paul giving a brief intro, and then we'll go back and forth with a Q&A. And if anybody has any questions, feel free to submit them through the portal. But anyway, Paul, over to you.

Paul Bolno
Wave Life Sciences Ltd. - President & CEO

Thanks, Alex. And we appreciate the time to update everybody on the continued progress at Wave. I mean, look, we're just -- we're focused now on what we've been since our foundation, which is on building a leading genetic medicines company, driving innovation in RNA therapeutics.

It's important to remember as well that our platform today really reflects now nearly a decade of investment in understanding new chemistries. And not just chirality, obviously that was -- our foundational principle is really understanding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot